Loss of Mbd2 Protects Mice Against High-Fat Diet–Induced Obesity and Insulin Resistance by Regulating the Homeostasis of Energy Storage and Expenditure

Previous studies including ours demonstrated that methyl-CpG–binding domain 2 (MBD2) acts as a reader to decipher DNA methylome-encoded information. We thus in the current study used Mbd2−/− mice as a model to dissect the impact of high-fat diet (HFD) on DNA methylome relevant to the pathoetiology of obesity. It was interestingly noted that mice deficient in Mbd2 were protected from HFD-induced obesity and insulin resistance. Mechanistic study revealed that HFD rendered epididymal adipose tissues to undergo a DNA methylation turnover as evidenced by the changes of methylation levels and patterns. Specifically, HFD was noted with higher potency to induce DNA hypomethylation in genes relevant to energy storage than that in genes associated with energy expenditure. As a result, arrays of genes were subjected to expression changes, which led to an altered homeostasis for energy storage and expenditure in favor of obesity development. Loss of Mbd2 resulted in impaired implementation of above DNA methylation changes associated with altered energy homeostasis, which then protected mice from HFD-induced obesity and insulin resistance. Those data would provide novel insight into the understanding of the pathoetiology underlying obesity with potential for developing effective therapies against obesity in clinical settings.

[1]  S. Shoelson,et al.  Adipose Natural Killer Cells Regulate Adipose Tissue Macrophages to Promote Insulin Resistance in Obesity. , 2016, Cell metabolism.

[2]  V. Stambolic,et al.  Obesity and cancer, a case for insulin signaling , 2015, Cell Death and Disease.

[3]  P. Møller,et al.  Involvement of MBD4 inactivation in mismatch repair-deficient tumorigenesis , 2015, Oncotarget.

[4]  Q. Ning,et al.  AAL exacerbates pro-inflammatory response in macrophages by regulating Mincle/Syk/Card9 signaling along with the Nlrp3 inflammasome assembly. , 2015, American journal of translational research.

[5]  O. Gavrilova,et al.  Celastrol Protects against Obesity and Metabolic Dysfunction through Activation of a HSF1-PGC1α Transcriptional Axis. , 2015, Cell metabolism.

[6]  X. Xiang,et al.  Chop deficiency prevents UUO-induced renal fibrosis by attenuating fibrotic signals originated from Hmgb1/TLR4/NFκB/IL-1β signaling , 2015, Cell Death and Disease.

[7]  D. Cota,et al.  Influence of mTOR in energy and metabolic homeostasis , 2014, Molecular and Cellular Endocrinology.

[8]  L. Wen,et al.  MBD2 regulates TH17 differentiation and experimental autoimmune encephalomyelitis by controlling the homeostasis of T-bet/Hlx axis. , 2014, Journal of autoimmunity.

[9]  K. McPherson.  Reducing the global prevalence of overweight and obesity , 2014, The Lancet.

[10]  B. Liu,et al.  A Novel Function of MicroRNA 130a-3p in Hepatic Insulin Sensitivity and Liver Steatosis , 2014, Diabetes.

[11]  J. Morrison,et al.  Epigenetics and human obesity , 2014, International Journal of Obesity.

[12]  Leif Groop,et al.  A Six Months Exercise Intervention Influences the Genome-wide DNA Methylation Pattern in Human Adipose Tissue , 2013, PLoS genetics.

[13]  Q. Lu,et al.  DNA methylation impairs TLR9 induced Foxp3 expression by attenuating IRF-7 binding activity in fulminant type 1 diabetes. , 2013, Journal of autoimmunity.

[14]  S. Murphy,et al.  Paternal obesity is associated with IGF2 hypomethylation in newborns: results from a Newborn Epigenetics Study (NEST) cohort , 2013, BMC Medicine.

[15]  M. Scharfe,et al.  Differential roles for MBD2 and MBD3 at methylated CpG islands, active promoters and binding to exon sequences , 2013, Nucleic acids research.

[16]  Daniel Adkins,et al.  MBD-seq as a cost-effective approach for methylome-wide association studies: demonstration in 1500 case--control samples. , 2012, Epigenomics.

[17]  M. Blüher,et al.  Ablation of TRIP-Br2, a novel regulator of fat lipolysis, thermogenesis and oxidative metabolism, prevents diet-induced obesity and insulin resistance , 2012, Nature Medicine.

[18]  M. Fraga,et al.  Effects of short-term high-fat overfeeding on genome-wide DNA methylation in the skeletal muscle of healthy young men , 2012, Diabetologia.

[19]  Huidong Shi,et al.  Loss of Methyl-CpG–Binding Domain Protein 2 Enhances Endothelial Angiogenesis and Protects Mice Against Hind-Limb Ischemic Injury , 2011, Circulation.

[20]  Margaret J. Morris,et al.  Chronic high-fat diet in fathers programs β-cell dysfunction in female rat offspring , 2010, Nature.

[21]  Y. Tseng,et al.  Cellular bioenergetics as a target for obesity therapy , 2010, Nature Reviews Drug Discovery.

[22]  B. Christensen,et al.  Aging and Environmental Exposures Alter Tissue-Specific DNA Methylation Dependent upon CpG Island Context , 2009, PLoS genetics.

[23]  Archana Dhasarathy,et al.  The MBD protein family-reading an epigenetic mark? , 2008, Mutation research.

[24]  A. Georgakilas,et al.  Oxidative stress, DNA methylation and carcinogenesis. , 2008, Cancer letters.

[25]  Masato Kasuga,et al.  Dok1 mediates high-fat diet–induced adipocyte hypertrophy and obesity through modulation of PPAR-γ phosphorylation , 2008, Nature Medicine.

[26]  G. Haegeman,et al.  Keeping up NF-kappaB appearances: epigenetic control of immunity or inflammation-triggered epigenetics. , 2006, Biochemical pharmacology.

[27]  P. Wade,et al.  MBD family proteins: reading the epigenetic code , 2006, Journal of Cell Science.

[28]  B. Teferedegne,et al.  Mechanism of Action of a Distal NF-κB-Dependent Enhancer , 2006, Molecular and Cellular Biology.

[29]  Gioacchino Natoli,et al.  Interactions of NF-κB with chromatin: the art of being at the right place at the right time , 2005, Nature Immunology.

[30]  Peter A. Jones,et al.  Epigenetics in human disease and prospects for epigenetic therapy , 2004, Nature.

[31]  Stephan Ladisch,et al.  Construction of long DNA molecules using long PCR-based fusion of several fragments simultaneously. , 2004, Nucleic acids research.

[32]  A. Bird,et al.  MBD4 deficiency reduces the apoptotic response to DNA-damaging agents in the murine small intestine , 2003, Oncogene.

[33]  E. Lein,et al.  Mice lacking methyl-CpG binding protein 1 have deficits in adult neurogenesis and hippocampal function , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Esteban Ballestar,et al.  The affinity of different MBD proteins for a specific methylated locus depends on their intrinsic binding properties. , 2003, Nucleic acids research.

[35]  Michael Karin,et al.  A central role for JNK in obesity and insulin resistance , 2002, Nature.

[36]  A. Bird,et al.  Closely related proteins MBD2 and MBD3 play distinctive but interacting roles in mouse development. , 2001, Genes & development.

[37]  Paul Tempst,et al.  MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex , 1999, Nature Genetics.

[38]  H. Sul,et al.  Understanding adipocyte differentiation. , 1998, Physiological reviews.

[39]  J. T. Wachsman,et al.  DNA methylation and the association between genetic and epigenetic changes: relation to carcinogenesis. , 1997, Mutation research.

[40]  J. Heeren,et al.  Adipose tissue browning and metabolic health , 2014, Nature Reviews Endocrinology.

[41]  B. Teferedegne,et al.  Mechanism of action of a distal NF-kappaB-dependent enhancer. , 2006, Molecular and cellular biology.

[42]  F. Bost,et al.  The role of MAPKs in adipocyte differentiation and obesity. , 2005, Biochimie.

[43]  A. Bird,et al.  A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome , 2001, Nature Genetics.